ADMA |
Asymmetric dimethylarginine |
AST |
aspartate aminotransferase |
BDL |
Bile duct ligation |
BDL + T |
Bile duct ligation + Treatment (L-NAME) |
cNOS |
constitutively expressed NOS |
DAB |
3,3-Diaminobenzidine |
ECM |
Extracellular matrix |
EMT |
Epithelial-to-mesenchymal transition |
eNOS |
Endothelial NOS |
HA |
Hyaluronic acid |
HIF-1α |
Hypoxia-inducible factor-1α |
HSC |
Hepatic stellate cells |
IF |
Immunofluoresence |
IHC |
Immunohistochemistry |
IL-6 |
Interleukin 6 |
iNOS |
Inducible NOS |
IRI |
Ischemia–reperfusion injury |
L-NAME |
N-Nitroarginine methyl ester |
MDA |
Malondialdehyde |
mRNA |
Messenger ribonucleic acid |
nNOS |
Neuronal NOS |
NO |
Nitric oxide |
NOS |
NO synthase(s) |
PM |
Pringle maneuver |
PVF |
Portal venous flow |
RT-qPCR |
Quantitative real-time polymerase chain reaction |
RECA-1 |
Rat endothelial cell antigen-1 |
TGF-β |
Transforming growth factor β |